LimmaTech Biologics AG
Susanna Fleurkens, PhD, is a skilled professional in the field of microbiology and glycoengineering, currently serving as a Preclinical Project Manager at LimmaTech Biologics AG since October 2022. Prior experience includes roles as a Senior Scientist and Scientist at Malcisbo Ltd. from March 2018 to October 2022, and as a Clinic Management Assistant at Universitätsspital Zürich in early 2018. Susanna completed a PhD at ETH Zurich, focusing on carbohydrate-based vaccines against the sheep parasite Haemonchus contortus, and has supervised Master students while contributing to numerous national and international conferences. Other positions held include a Scientific Associate at ETH Zurich, an internship at Utrecht University, and a postgraduate internship at Novartis Institutes for BioMedical Research. Educational qualifications include a BSc and MSc from ETH Zurich in Biology and Microbiology and Immunology, respectively.
This person is not in any teams
LimmaTech Biologics AG
LimmaTech Biologics AG is a Swiss-based clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antibiotic resistance (AMR) and sexually transmitted diseases. In addition to our proprietary research, we also develop vaccines together with GSK.